Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the press notice entitled Major agreement to deliver new cancer vaccine trials, published on 5 July 2023, whether brain cancer patients will be given access to the treatments and therapies made available through that programme.

The Government’s partnership with BioNTech aims to provide up to 10,000 United Kingdom patients with personalised immunotherapies by 2030. As well as cancer vaccines, BioNTech has several other classes of cancer therapy under development, such as engineered cell therapies and antibodies. We are not able to comment at this stage on the exact pipeline of clinical trials that BioNTech will go on to launch in the UK, over the coming years.